TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
UTHR

United Therapeutics Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

497.30$ -0.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

United Therapeutics Corporation (UTHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 3,183 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement UTHR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1,289 1,466 1,599 1,725 1,628 1,449 1,483 1,686 1,936 2,328 2,877 3,183
126 69 73 106 199 118 108 123 147 258 310 384
1,163 1,397 1,526 1,620 1,429 1,331 1,375 1,563 1,790 2,070 2,568 2,798
243 245 148 265 358 1,183 358 540 323 408 481 550
299 358 232 266 207 276 369 403 416 395 542 613
624 698 464 595 624 1,519 782 1,007 810 885 1,191 1,281
539 699 1,062 815 805 -188 594 556 980 1,185 1,377 1,517
18 4.7 3.9 9.0 14 44 24 19 32 59 43 20
525 1,044 1,060 770 759 -165 639 594 951 1,274 1,539 1,714
185 393 347 352 170 -61 124 118 223 290 344 379
340 652 714 418 589 -105 515 476 727 985 1,195 1,335
575 1,082 1,091 1,053 838 -75 646 737 1,040 1,387 1,654 1,819

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?